Sven Björkman

Consensus perspectives on prophylactic therapy for haemophilia: summary statement

Erik Berntorp, Jan Astermark, Sven Björkman et al. · Haemophilia · 2003 · 270 citations · Full text

Consensus Summary, Preventive Medicine, Secondary Prophylaxis +14

Prediction of drug disposition in infants and children by means of physiologically based pharmacokinetic (PBPK) modelling: theophylline and midazolam as model drugs

Sven Björkman · British Journal of Clinical Pharmacology · 2004 · 241 citations · Full text

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Sven Björkman, Myungshin Oh, Gerald Spotts et al. · Blood · 2011 · 204 citations · Full text

Factor VIII requirement to maintain a target plasma level in the prophylactic treatment of severe hemophilia A: influences of variance in pharmacokinetics and treatment regimens

Peter W. Collins, Sven Björkman, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2009 · 186 citations

Thrombosis, Hematology, Hemostasis +8

Pharmacokinetics and dose requirements of factor VIII over the age range 3–74 years

Sven Björkman, Anna Folkesson, Siv Jönsson · European Journal of Clinical Pharmacology · 2009 · 149 citations · Full text

Dose Requirements, Hematology, Age Range 3–74 +3